The Problem: Use of Zantac, a popular heartburn drug, is allegedly linked to stomach, bladder and other cancers
The Response: The FDA has issued advisories and Zantac and all Ranitidine drugs have been pulled from the market
What Can We Do to Help: Our experienced attorneys can review your medical records and advise you if filing a case is in your best interest
The attorneys at Gallon, Takacs & Boissoneault are investigating a suspected link between use of Zantac (Ranitidine) a popular heartburn medication and cancer, especially stomach and bladder cancer. Have you or anyone you know developed bladder or stomach cancer after the use of Zantac? If so contact us today. Find out if you can seek compensation for your injuries by completing our free case evaluation.
It is alleged that the high levels of the cancer-causing chemical N-Nitrosodimethylamine, or NDMA, in Zantac can increase the risk of bladder, stomach and other cancers.
On April 1, 2020 the Food and Drug Administration (FDA) posted a news release concerning Zantac. “The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S.”
Zantac and other Ranitidine containing drugs were created to prevent acid reflux issues like gastroesophageal reflux disease (GERD) and chronic heartburn. While some formulations of the drug are available over the counter, other stronger formulations are available by prescription only and are meant to treat more severe cases of acid reflux. The drug works as a histamine (H2) blocker, meant to prevent the stomach from releasing too much acid.
Zantac lawsuits claim high levels of the cancer-causing chemical N-Nitrosodimethylamine, or NDMA, in the medication can increase the risk of bladder, stomach and other cancers. According to the U.S. Food and Drug Administration, the acceptable daily level of NDMA is 96 nanograms, but tests found that the amount in a single pill far exceeds that limit.
The allegations against Zantac are new and changing rapidly. If you or anyone you know has developed bladder or stomach cancer, or any complications, contact us today.